A federal grant for HIV research is part of $15.7 million the National Institutes for Health awarded to the Wertheim UF Scripps Institute in Jupiter.

A new long-acting medicine that could make preventing HIV transition might soon be even for poor countries like Uganda thanks to agreements between producers and key HIV/AIDS prevention programme ...

How much prison time is too much? How harsh are speeding penalties? Should people be charged for passing on an infection, and ...

In a preclinical study, UC Davis Comprehensive Cancer Center scientists have developed a highly targeted gene therapy that ...

Scientists have developed a genetic “Trojan horse” therapy that targets and kills cancer cells tied to Kaposi’s sarcoma, with ...

A generic version of the HIV prevention medicine will cost $40 per year, although there are concerns about whether it can reach all who need it. Sophie Cousins reports.

India is one of the countries with the most affordable medicines. This is why Indian medicines are so popular even in ...

Why fall in Scotland's drug deaths may be just the calm before the nitazene storm How drug deaths could soon be surpassed by number of patients dying because of long A&E waits in Scotland Drug deaths ...

Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage – NV-387 Could Become a Revolutionary Antiviral for Respiratory Viral Infections SHELTON, CONNECTICUT / ACCESS Newswire / September 30, ...

What if the presence of a well-known but misunderstood viral protein explains why some people living with HIV (PLWH) never ...

Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global ...